Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,151–3,175 of 7,816 matching trials · page 127 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Feasibility of Using an App for Managing Phantom Limb Pain Associated with Combat Injury in Ukraine (PAMELA) NCT06604507 non-pharmacological app Runs in: Ukraine · 5 sites |
NA other |
NOT_YET_RECRUITING | 200 | Winfried Meißner OTHER |
2024-09-19 |
|
Deep Brain Stimulation with LIFUP for Mild Cognitive Impairment and Mild Alzheimer's Disease NCT03347084 Excitation; Inhibition Runs in: United States · 1 site |
NA other |
COMPLETED | 2 | University of California, Los Angeles OTHER |
2024-09-05 |
|
Medication Misuse and Dependence Among Elderly NCT03162081 Substance misuse screening; EQ-5D; Impulsivity screening; Cognitive... Runs in: Norway · 1 site |
NA other |
UNKNOWN | 500 | University Hospital, Akershus OTHER |
2024-09-04 |
|
Prospective Huntington At Risk Observational Study NCT00052143 Runs in: Canada; United States · 42 sites |
NA other |
COMPLETED | 1,001 | Huntington Study Group NETWORK |
2024-09-03 |
|
Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15) NCT06583161 Moderate drinking; Quitting; Social drinking; Heavy/binge drinking |
NA other |
COMPLETED | 503,325 | Harvard School of Public Health (HSPH) OTHER |
2024-09-03 |
|
The Effectiveness of Virtual Reality Training Program NCT06575218 Virtual reality training; Conventional exercise and cognitive exerc... Runs in: Turkey (Türkiye) · 1 site |
NA other |
UNKNOWN | 45 | Yeditepe University OTHER |
2024-08-30 |
|
Feasibility Study of Virtual Sail 3D in Cognitive Functions NCT06579378 VSail 3D; WEB-Health Runs in: Italy · 1 site |
NA other |
UNKNOWN | 40 | University of Cagliari OTHER |
2024-08-30 |
|
Effects of Tolcapone on Frontotemporal Dementia NCT00604591 Tolcapone; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 28 | Columbia University OTHER |
2024-08-28 |
|
Study on Ginkgo Biolba Extract Fifty and Mild Cognitive Impairment Associated With CSVD NCT06495476 Ginkgo biloba extract 50 dropping pills; Ginkgo biloba extract Gink... |
PHASE4 other |
UNKNOWN | 144 | Beijing Tiantan Hospital OTHER |
2024-08-28 |
|
Implication of Cognitive Reserve in Non-pharmacological Intervention Outcomes NCT06563453 transcranial alternating current stimulation Runs in: Czechia · 1 site |
NA other |
UNKNOWN | 55 | Masaryk University OTHER |
2024-08-28 |
|
The Effect of Antihypertensive Medication Timing on Morbidity and Mortality NCT02990663 Use of blood pressure lowering medication at bedtime; Use of blood ... Runs in: Canada · 5 sites |
PHASE4 other |
COMPLETED | 3,357 | University of Alberta OTHER |
2024-08-27 |
|
Indiana Palliative Excellence in Alzheimer's Care Efforts NCT03773757 IN-PEACE Dementia Care Coordination Runs in: United States · 1 site |
NA other |
COMPLETED | 402 | Indiana University OTHER |
2024-08-27 |
|
BedMed-Frail: Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations? NCT04054648 Bedtime administration of the participant's pre-existing antihypert... Runs in: Canada · 1 site |
NA other |
COMPLETED | 776 | University of Alberta OTHER |
2024-08-27 |
|
Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923 NCT04805983 BMS-984923 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 36 | Yale University OTHER |
2024-08-27 |
|
Evaluation of Cognitive and Physical Training on MCI Elders NCT06572878 Cognitive training; Physical training; Combined cognitive and physi... |
NA other |
NOT_YET_RECRUITING | 144 | Taipei Medical University OTHER |
2024-08-27 |
|
Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound NCT04118764 Neuronavigation-guided single-element focused ultrasound transducer... Runs in: United States · 1 site |
NA other |
COMPLETED | 6 | Columbia University OTHER |
2024-08-26 |
|
Gentle Gymnastics and Relationship Between Family Caregivers and Residents With Dementia in Nursing Homes NCT05686486 Tai Chi inspired gymnastics Runs in: France · 4 sites |
NA other |
COMPLETED | 28 | Fondation Mederic Alzheimer OTHER |
2024-08-26 |
|
Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease NCT02787746 Donepezil Runs in: China · 1 site |
PHASE4 symptomatic-cholinergic |
COMPLETED | 241 | Beijing Friendship Hospital OTHER |
2024-08-23 |
|
Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) NCT02843529 Altoida: neuropsychological, MRI, EEG and CSF biomarkers |
NA other |
COMPLETED | 548 | Altoida INDUSTRY |
2024-08-23 |
|
Assessment of Medication Optimization in Rural Kentucky Appalachian Patients With Mild Cognitive Impairment or Dementia NCT05078437 Medication therapy management Runs in: United States · 1 site |
NA other |
TERMINATED | 16 | Daniela Moga OTHER |
2024-08-23 |
|
CONFIDENCE Financial Education for Caregivers NCT05292248 Confidently Navigating Financial Decisions and Enhancing Financial ... Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | Case Western Reserve University OTHER |
2024-08-23 |
|
ARUA-ALZ - Connecting Audio and Radio SensingmSystems to Improve Care at Home for ADRD NCT06170528 AURA_ALZ Runs in: United States · 1 site |
NA other |
COMPLETED | 9 | Florida State University OTHER |
2024-08-23 |
|
SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD) NCT04381468 Pepinemab; Placebo Runs in: United States · 14 sites |
PHASE1|PHASE2 other |
COMPLETED | 50 | Vaccinex Inc. INDUSTRY |
2024-08-22 |
|
Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease Diagnosis NCT05020626 Runs in: Hong Kong · 1 site |
NA other |
UNKNOWN | 250 | Chinese University of Hong Kong OTHER |
2024-08-22 |
|
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants NCT06226064 VES001; Placebo Runs in: Netherlands · 1 site |
PHASE1 other |
COMPLETED | 78 | Vesper Biotechnologies ApS INDUSTRY |
2024-08-22 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial